Press Releases

Date	Title and Summary	Additional Formats
Toggle Summary Jun 25,2014	Amphastar Pharmaceuticals Announces Pricing of Initial Public Offering RANCHO CUCAMONGA, Calif., June 25, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Amphastar) (Nasdaq:AMPH), a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable and	View HTML Amphastar Pharmaceuticals Announces Pricing of Initial Public Offering 19.4 KB

This site is intended for residents of the United States